Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-17

FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CRESEMBA (isavuconazonium sulfate) submitted by Astellas Pharma US, expanding the approval through a supplemental su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cresemba (isavuconazole)

Snippet

SUPPL AP for CRESEMBA (ISAVUCONAZONIUM SULFATE)